Elaine Hyshka Publications

Select publications

2022

Brooks HL, Salvalaggio G, Pauly B, Dong K, Bubela T, Taylor M, Hyshka E. (2022). “I have such a hard time hitting myself, I thought it’d be easier”: perspectives of hospitalized patients on injecting drugs into vascular access devices. Harm Reduct J. 19(1):54. doi: 10.1186/s12954-022-00637-1.
Salvalaggio, G., Ferguson, L., Brooks, H.L., Hyshka, E., et al. (2022). Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol. Syst Rev 11(66). https://doi.org/10.1186/s13643-022-01938-z
Weicker SA, Speed KA, Hyshka E, Mrochuk M, Kosteniuk B, Dong K. (2022). Emergency department care for patients who use opioids during the COVID-19 pandemic. CJEM. 24(2):123-125. doi: 10.1007/s43678-021-00229-1. Epub 2021 Nov 24.
Gehring ND, Speed KA, Launier K, O’Brien D, Campbell S, Hyshka E. (2022). The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature. Int J Drug Policy. 102:103589. doi: 10.1016/j.drugpo.2022.103589.
Salvalaggio G, Dong KA, Hyshka E, McCabe C, Nixon L, Rosychuk RJ, Dmitrienko K, Krajnak J, Mrklas K, Wild TC. (2022). Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study. Subst Abuse Treat Prev Policy. 17(1):20. doi: 10.1186/s13011-022-00445-7.
Williams RJ, Belanger YD, Leonard CA, Stevens RMG, Christensen DR, El-Guebaly N, Hodgins DC, McGrath DS. (2022). Indigenous Gambling and Problem Gambling in Canada. J Gambl Stud. 38(1):67-85

2021

Jenkins E, Slemon A, Morris H, Hyshka E, Schulz P, Haines-Saah RJ. (2021). Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis. Int J Drug Policy. 91:103011. doi: 10.1016/j.drugpo.2020.103011. Epub 2020 Oct 27.
Lee C, Voaklander D, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada. Inj Epidemiol. 8(1):33. doi: 10.1186/s40621-021-00321-1.
Lee C, Lin M, Martins KJB, Dyck JRB, Klarenbach S, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2021). Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada. BMC Public Health. 21(1):843. doi: 10.1186/s12889-021-10867-w.
Kosteniuk B, Salvalaggio G, McNeil R, Brooks HL, Dong K, Twan S, Brouwer J, Hyshka E. (2021). “You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care. Int J Drug Policy. 96:103275. doi: 10.1016/j.drugpo.2021.103275.
Lee C, Lin M, Martins KJB, Dyck JRB, Klarenbach S, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2021). Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada. BMC Public Health. 21(1):843. doi: 10.1186/s12889-021-10867-w.
Lee C, Round JM, Klarenbach S, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. Harm Reduct J. 18(1):61. doi: 10.1186/s12954-021-00509-0.
Lee C, Round JM, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada. Can J Psychiatry. 7067437211043393. doi: 10.1177/07067437211043393.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT. (2021). Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study. BMC Cardiovasc Disord. 21(1):426. doi: 10.1186/s12872-021-02229-6.
Zongo A, Lee C, El-Mourad J, Dyck JRB, Hyshka E, Hanlon JG, Eurich DT. (2021). Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study Can J Psychiatry. doi: 10.1177/07067437211060597.
Biggar E, Papamihali K, Leclerc P, Hyshka E, Graham B, Taylor M, Payer D, Maloney-Hall B, Buxton JA. (2021). Towards cross-Canada monitoring of the unregulated street drug supply. BMC Public Health. 2021 Sep 15;21(1):1678. doi: 10.1186/s12889-021-11757-x.
Kosteniuk B, Salvalaggio G, Wild TC, Gelberg L, Hyshka E. (2021). Perceived unmet substance use and mental health care needs of acute care patients who use drugs: A cross-sectional analysis using the Behavioral Model for Vulnerable Populations. Drug Alcohol Rev. doi: 10.1111/dar.13417.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2021). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. 74(3):299-304. doi: 10.1136/jech-2019-212438. Epub 2019 Dec 12.
Morris, H., Schulz, P., Jenkins, E., Haines-Saah, R., Hyshka, E. (2021). “I’m not your reality show:” Perspectives of bereaved mothers’ engagement with the news media to advance drug policy reform. SSM – Qualitative Research in Health. 1;100011.
Morris, H., Hyshka, E., Schulz, P., Jenkins, E., Haines-Saah, R. (2021). “It’s a Bit of a Double-Edged Sword”: Motivation and Personal Impact of Bereaved Mothers’ Advocacy for Drug Policy Reform. Qualitative Health Research. 31(10);1812-22.
Wild TC, Koziel J, Anderson-Baron J, Asbridge M, Belle-Isle L, Dell C, Elliott R, Hathaway A, MacPherson D, McBride K, Pauly B, Strike C, Galovan A, Hyshka E. (2021). Public support for harm reduction: A population survey of Canadian adults. PLoS One. 16(5):e0251860. doi: 10.1371/journal.pone.0251860.

2020

O’Keefe-Markman C, Lea KD, McCabe C, Hyshka E, Bubela T. (2020). Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment. BMC Public Health. 20(1):89. doi: 10.1186/s12889-020-8190-2.
Milaney K, Williams N, Lockerbie SL, Dutton DJ, Hyshka E. (2020). Recognizing and responding to women experiencing homelessness with gendered and trauma-informed care. BMC Public Health. 20(1):397. doi: 10.1186/s12889-020-8353-1.
Dong KA, Brouwer J, Johnston C, Hyshka E. (2020). Supervised consumption services for acute care hospital patients. CMAJ. 192(18):E476-E479. doi: 10.1503/cmaj.191365.
Round JM, Lee C, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20(1):987. doi: 10.1186/s12889-020-09089-3.
Brooks HL, Husband C, Taylor M, Sherren A, Hyshka E. (2020). Supporting the full participation of people who use drugs in policy fora: Provision of a temporary, conference-based overdose prevention site. Int J Drug Policy. 84:102878. doi: 10.1016/j.drugpo.2020.102878. Epub 2020 Jul 30.
Speed KA, Gehring ND, Launier K, O’Brien D, Campbell S, Hyshka E. (2020). To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities. Harm Reduct J. 17(1):72. doi: 10.1186/s12954-020-00414-y.
Dong KA, Brouwer J, Johnston C, Hyshka E. (2020). Supervised consumption services for acute care hospital inpatients. CMAJ. 192:E476-9. DOI: 10.1503/cmaj.191365.
Jenkins, El, Slemon, A., Morris, H., Hyshka, E., Schulz, P., Haines-Saah, R.J. (2020). Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2020.103011
Milaney, K., Williams, N., Lockerbie, S.L., Dutton, D.J., Hyshka, E. (2020). Recognizing and responding to women experiencing homelessness with gendered and trauma-informed care. BMC Public Health. 20, 397.
Pawliuk C, Park M, Buxton JA on behalf of the Overdose Crisis Knowledge Synthesis Working Group. (2020). Legal approaches and government policies enacted to address the overdose epidemic: A scoping review protocol. JBI Evidence Synthesis. doi: 10.11124/JBISRIR-D-19-00296.
Round JM, Lee C, Hanlon JG, Hyshka E, Dyck J, Eurich D. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20:987. DOI: 1186/s12889-020-09089-3.

2019

Brooks HL, O’Brien D, Salvalaggio G, Dong K, Hyshka E. (2019). Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs. Drug & Alcohol Review.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2019). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. pii: jech-2019-212438.
Hyshka, E., Morris, H., Anderson-Baron, J., Nixon, L., Dong, K., & Salvalaggio, G. (2019). Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug and Alcohol Dependence. 204, 107523.
Hyshka, E., Anderson-Baron, L., Pugh, A., Belle-Isle, L., Hathaway, A., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Tupper, K., Wild, C. (2019). Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada. International Journal of Drug Policy. 71, 142-149.
Lee C, Voaklander D, Minhas-Sandhu JK, Dyck J, Hanlon JG, Hyshka E, Eurich DT. (2019). Cohort study of medical cannabis authorizations and motor vehicle accident-related healthcare visits in 2014-2017 in Ontario, Canada. Revision requested. Injury Prevention.
Morris H, Hagen L, Hyshka E, Francescutti LH. (2019). Empowering Students and Influencing Policy Change Through Experiential Public Health Advocacy Education. J Nurs Educ. 58(12), 698-703.
O’Brien, D. C., Dabbs, D., Dong, K., Veugelers, P. J., & Hyshka, E. (2019). Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: A retrospective chart review. BMC Health Services Research. 19(1), 1-12.
Watson TM, Valleriani J, Hyshka E, Rueda S. (2019). Cannabis legalization in the provinces and territories: Missing opportunities to effectively educate youth? Canadian Journal of Public Health. 110(4), 472-475.
Watson TM, Hyshka E, Bonato S, Rueda S. (2019). Early-stage cannabis regulatory policy planning across Canada’s four largest provinces: A descriptive overview. Substance Use & Misuse. 54(10), 1691-1704.
Wild, C., Kozie, J., Anderson-Barron, J., Hathaway, J., McCurdy, A., Xu, X., . . . Hyshka, E. (2019). Media coverage of harm reduction, 2000-2016: A content analysis of tone, topics, and interventions in Canadian print news. Drug and Alcohol Dependence. 205, 107599.
Yakovenko, I., Hyshka, E., Tyrrell, L., & Wild, T. (2019). Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs. Journal of Substance Abuse Treatment. 101, 67-71.

2018

Brooks HL, Kassam S, Salvalaggio G, Hyshka E. (2018). Implementing managed alcohol programs in hospital settings: A review of academic and grey literature. Drug Alcohol Rev. 37 Suppl 1:S145-S155.

2017

Hyshka E., Anderson J.T., Wild T.C. (2017). Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs. Drug and Alcohol Review. 36(3), 295-304.
Hyshka, E., Anderson-Baron,J., Karekezi, K., Belle-Isle, L., Elliott, R., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Hathaway, A., & Wild, T.C. (2017). Harm reduction in name but not substance: A comparative analysis of Canadian provincial and territorial policy frameworks. Harm Reduction Journal, 14,50.
Hyshka, E., Karekezi, K., Tan, B., Slater, L.G., Jahrig, J., & Wild, T.C. (2017). The role of consumer perspectives in estimating population need for substance use services: A scoping review. BMC Health Services Research, 36(3),295-304.
Wild, T., Pauly, B., Belle-Isle, L., Cavalieri, W., Elliott, R., Strike, C., Tupper, K., Hathaway, A., Dell, C., MacPherson, D., Sinclair, C., Karekezi, K., Tan, B., Hyshka, E. (2017) Canadian Harm Reduction Policies: A Comparative Content Analysis of Provincial and Territorial Documents, 2000-2015”. International Journal of Drug Policy. 45, 9-17.

2016

Kirst M, Kolar K, Chaiton M, Schwartz R, Emerson B, Hyshka E, Jesseman R, Lucas P, Solomon R, Thomas G. (2016). A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health. 106(8):e474-6.
Salvalaggio, G., Dong, K.A., Hyshka, E., Nixon, L., Lavergne, K., Nicol, J., Louis, M., Lockerbie, S., Bristowe, M., Leske, J., Rosychuk, R.J., Mrklas, K., Surood, S., & Wild, T.C. (2016). Enhanced multidisciplinary care for inner city patients with high acute care use: Study protocol. Canadian Journal of Addiction. 7(3),34-41.

2015 and earlier

Hyshka E, Bubela T, Wild TC. (2013). Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making. Addiction. 108(3), 468-76.
Kerr T, Small W, Hyshka E, Maher L, Shannon K. (2013). ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction. 108(7), 1270-6.
Hyshka E, Strathdee S, Wood E, Kerr T. (2012). Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 23(4), 261-70.
Hyshka E, Butler-McPhee J, Elliott R, Wood E, Kerr T. (2012). Canada moving backwards on illegal drugs. Can J Public Health. 103(2), 125-7.
Hyshka E, Erickson PG, Hathaway A. (2011). The time for marijuana decriminalization has come again . . . and again. Criminal Law Bulletin. 47(2):258-275.
Erickson PG, Hyshka E. (2010). Four decades of cannabis criminals in Canada 1970-2010. Amsterdam Law Forum. 2(4):14.
Hathaway A, Hyshka E, Erickson PG, Asbridge M, Brochu S, Cousineau MM, Duff C, Marsh D. (2010). Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduction Journal. 7:15.
Hyshka E. (2009). The Saga Continues: Canadian Legislative Attempts to Reform Cannabis Law in the Twenty-First Century. Canadian Journal of Criminology and Criminal Justice. 51(1), 73–91.
Hyshka, E. (2009). Turning failure into success: what does the case of Western Australia tell us about Canadian cannabis policy-making? Policy Studies. 30(5), 513–531.
Kerr T, Small W, Hyshka E, Maher L, Shannon K. (2013). ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction. 108(7), 1270-6.